STOCKHOLM--(BUSINESS WIRE)--This release replaces the one issued on November 23, 2016, in which the last day of trading on Nasdaq Helsinki was incorrectly stated to be December 7, 2016. Due to Nasdaq Helsinki’s Exchange rules, the last day of trading in the warrant must be the fourth trading day immediately preceding the last subscription day. This means that the last trading day for ENDOMEW114 in Helsinki will be December 2, 2016.
The corrected release reads:
ENDOMINES AB: REMINDER OF LAST DAY OF TRADING IN THE WARRANT 2014/2016
The exercise period for Endomines warrants 2014/2016 will begin on November 28th 2016 and end on December 9th 2016. The last day of trading in the warrant on Nasdaq Stockholm is on December 7th 2016. The last day of trading on Nasdaq Helsinki will be December 2, 2016.
One (1) warrant entitles to subscription of 0.0072 newly issued shares at a price of SEK 38 per share. This corresponds to one (1) new share per 139 warrants.
The subscription price for shareholders whose shares are registered in Finland is in euro. The subscription price is determined based on Sveriges Riksbank’s official EUR/SEK exchange rate three days before each specific subscription period. The subscription price has been determined to 3.88 euro per share.
Directly registered holders of warrants (only in Sweden) are asked to fill in an application form, which can be downloaded on Endomines’ website, www.endomines.com. Subscription takes place simultaneously with payment as instructed on the application form.
Nominee registered warrant holders (in Sweden and Finland) are requested to contact their nominee for instructions regarding subscription and payment.
For other terms regarding the warrants, please refer to the prospectus for the rights issue 2014 (in Swedish only) as well as the recalculation of the terms of the warrants after the share issue and reverse split in 2016.
Note that the warrants must be exercised not later than December 9th 2016 or sold not later than December 7th 2016, in order not to expire. To avoid the warrants from being expired you are required to actively subscribe to new shares or alternatively sell your warrants.
This information is information that Endomines AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Market Act. The information was submitted for publication, through the agency of the contact persons set out above, at 17:35 CET on NOVEMBER 23, 2016.
Endomines (STO:ENDO)(HEX:ENDOM) is a gold concentrate producer with mining, development and exploration operations in Eastern Finland along the 40 kilometer long Karelian Gold Line. Through various regulatory approvals, Endomines controls the exploration rights to this entire area. Endomines vision is to participate in the future structural transformation and consolidation of the Nordic mining industry. The Company may therefore be involved in acquisitions of interesting deposits or companies, should such opportunities arise.
The shares trade on Nasdaq Stockholm (ENDO) and Nasdaq Helsinki (ENDOM).
This information was brought to you by Cision http://news.cision.com